Advances in Systemic Amyloidosis: A Spotlight on New Disease-Modifying Therapies Across the Clinical Spectrum

Explore recent advances in amyloidosis treatment and management with an expert-authored interactive actvity a commentary and a downloadable slideset.

Share

Program Content

Activities

Managing AL and ATTR Amyloidosis
Advances in Systemic Amyloidosis: A Spotlight on New Disease-Modifying Therapies Across the Clinical Spectrum
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2021

Expires: October 20, 2022

Slides: Managing AL and ATTR Amyloidosis
Advances in Systemic Amyloidosis: A Spotlight on New Disease-Modifying Therapies Across the Clinical Spectrum
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2021

Expires: October 20, 2022

Activities

AL Amyloidosis
Getting to Know Light-Chain Amyloidosis: My Thoughts on Recent Progress
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 17, 2021

Expires: August 16, 2022

Activities

<i>EP</i>: Amyloidosis advances
ExpressPoints
Advances in Systemic Amyloidosis: A Spotlight on New Disease-Modifying Therapies Across the Clinical Spectrum
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: October 18, 2021

Expires: October 17, 2022

Faculty

cover img faculity

Raymond L. Comenzo, MD

Director, Blood Bank and Stem Cell Processing Laboratory
Tufts Medical Center
Professor of Medicine and Pathology
Tufts University School of Medicine
Boston, Massachusetts

cover img faculity

Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO

Cleveland Clinic Taussig Cancer Institute
Department of Hematology and Medical Oncology
Member, Population and Cancer Prevention Program, Case Comprehensive Cancer Center
Cleveland, Ohio

cover img faculity

Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Chair, Myeloma, Amyloidosis and Dysproteinemia Group
Research Chair, Division of Hematology
Mayo Clinic
Rochester, Minnesota

Provided by

ProCE Banner

Supporters

Supported by an educational grant from

Janssen administered by Scientific Affairs